Table 1. Correlations between diaphyseal or metaphyseal BMD determined by bone histomorphometry and in vivo μCT, ex vivo specimen μCT or ex vivo DXA 10 weeks after tumor inoculation.

Technique	BMD At diaphysis		BMD At metaphysis
	r	P	r	P
91 µm vs DXA	0.83	<0.001	-	-
31 µm vs DXA	0.73	<0.001	-	-
16 µm va DXA	0.75	<0.001	-	-
91 µm vs 31 µm	0.93	<0.001	0.95	<0.001
91 µm vs 16 µm	0.94	<0.001	0.95	<0.001
91 µm vs 8 µm	-	-	0.97	<0.001
31 µm vs 16 µm	0.98	<0.001	0.96	<0.001
31 µm vs 8 µm	-	-	0.95	<0.001
16 µm vs 8 µm	-	-	0.97	<0.001
91 µm vsHistomorphometry	0.92	<0.001	0.78	<0.001
31 µm vsHistomorphometry	0.91	<0.001	0.75	<0.001
16 µm vsHistomorphometry	0.92	<0.001	0.77	<0.001
8 µm vsHistomorphometry	-	-	0.84	<0.001
DXA vsHistomorphometry	0.73	<0.001	-	-

*In vivo μCT, 91 µm; Ex vivo μCT, 31, 16, 8 µm.